Benzodiazepine Study for the Treatment of Seizure Clusters in a Third Level Mexican Neurological Center
An Open Label Benzodiazepine Study for the Treatment of Seizure Clusters in a Third Level Mexican Neurological Center
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
150 participants
May 1, 2023
INTERVENTIONAL
Conditions
Summary
The aim of this study is to determine the efficacy in seizure reduction when comparing orodispersable clonazepam versus usual treatment (i.e. medication load, intravenous high- dose benzodiazepines) of seizure clusters in a third level center of care in Mexico city.
Eligibility
Inclusion Criteria4
- At least age of 18
- Patient available for follow-up
- Previous diagnosis of epilepsy
- Patient meets criteria for seizure clusters (3 or more seizures in a period of 24 hours)
Exclusion Criteria6
- Risk factors for epilepsy have been identified and uncontrolled.
- Younger than 18 years olf
- Follow- up in another healthcare unit
- No previous epilepsy diagnosis
- Adequate control of epilepsy
- Patient meets criteria for clinical or electrographic status epilepticus.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Buccal administration
Orodispersable
Medication that is usually used in the emergency department
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06056349